Medical device company Q'Apel Medical reported on Tuesday the receipt of US Food and Drug Administration clearance for its novel walrus Balloon Guide Catheter (BGC) for the neurovascular market.
The US FDA approved walrus BGC, with its 087 ID, marks a big step forward in balloon guide catheter technology and for stroke patients worldwide, added the company .
In conjunction, the walrus BGC represents the company's second US FDA-cleared technology in the past 12 months, joining the wahoo Access Catheter with Selectflex technology.
Additionally, the company expects to launch more innovative neurovascular products with speed, reliability and performance slated in the market over next year.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project